Daiken Biomedical Co (TPE:7780) Total Assets: NT$5,913 Mil (As of Dec. 2025)


TPE:7780 Daiken Biomedical Co Ltd TPE:7780
23 GF Score
Price NT$18.00
! 6 Warning Signs
View Full Analysis

What is Daiken Biomedical Co Total Assets?

Daiken Biomedical Co TPE:7780 -1.91% 23 Total Assets is NT$5,913 Mil as of Dec. 2025. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review.

Daiken Biomedical Co's Total Assets for the quarter that ended in Dec. 2025 was NT$5,913 Mil.

During the past 12 months, Daiken Biomedical Co's average Total Assets Growth Rate was 63.40% per year. During the past 3 years, the average Total Assets Growth Rate was 36.50% per year.

During the past 4 years, Daiken Biomedical Co's highest 3-Year average Total Assets Growth Rate was 36.50%. The lowest was 36.50%. And the median was 36.50%.

Total Assets is connected with ROA %. Daiken Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 was 8.62%. Total Assets is also linked to Revenue through Asset Turnover. Daiken Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.11.

Daiken Biomedical Co  (TPE:7780) Total Assets Explanation

Total Assets is connected with ROA %.

Daiken Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=498.576/( (5653.314+5912.651)/ 2 )
=498.576/5782.9825
=8.62 %

Note: The Net Income data used here is four times the quarterly (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Daiken Biomedical Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Sep. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=656.111/( (5653.314+5912.651)/ 2 )
=656.111/5782.9825
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Daiken Biomedical Co Total Assets Related Terms

Daiken Biomedical Co Total Assets Historical Data

* Premium members only.

The historical data trend for Daiken Biomedical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiken Biomedical Co Total Assets Chart

Daiken Biomedical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Assets
530.17 745.17 1,537.80 5,912.65

Daiken Biomedical Co Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1,537.80 1,664.13 1,685.05 5,653.31 5,912.65
TPE:7780
23GF Score
Daiken Biomedical Co Ltd TPE:7780
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiken Biomedical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Daiken Biomedical Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=5442.704+469.947
=5,913

Daiken Biomedical Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=5442.704+469.947
=5,913

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of NT$5,913 Mil mean?
Daiken Biomedical Co (TPE:7780) has a Total Assets of NT$5,913 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Daiken Biomedical Co and its competitors.
Is Daiken Biomedical Co's Total Assets too high?
Daiken Biomedical Co's current Total Assets is NT$5,913 Mil. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's Total Assets compare to KHC and GIS?
Daiken Biomedical Co's Total Assets of NT$5,913 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Consumer Packaged Goods company?
A good Total Assets depends on the Consumer Packaged Goods industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Daiken Biomedical Co and its competitors. Daiken Biomedical Co's current Total Assets is NT$5,913 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current Total Assets of NT$5,913 Mil. The current Total Assets is NT$5,913 Mil. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current Total Assets is NT$5,913 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Daiken Biomedical Co Business Description

Address Roosevelt Road, 12th Floor, No. 37, Section 3, Daan District, Taipei, TWN
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score

Get the complete analysis for TPE:7780

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.00
Price